Vericel Corp
VCEL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000887359
In the last 90 days, Vericel Corp insiders filed 0 open-market purchases and 3 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $2.47B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Vericel Corp as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 205
- +1 vs. Q1 2021
- Shares held
- 48.9M
- +2.05M (+4.4%) vs. Q1 2021
- Total value
- $2.57B
- −$33.9M (−1.3%) vs. Q1 2021
- New holders
- 36
- 69 more added
- Sold out
- 35
- 82 more reduced
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VCEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 320 | $2.47B |
| Q1 2026 | 280 | $1.78B |
| Q4 2025 | 274 | $1.93B |
| Q3 2025 | 249 | $1.67B |
| Q2 2025 | 273 | $2.35B |
| Q1 2025 | 277 | $2.39B |
| Q4 2024 | 278 | $2.87B |
| Q3 2024 | 268 | $2.15B |
| Q2 2024 | 261 | $2.32B |
| Q1 2024 | 257 | $2.68B |
| Q4 2023 | 227 | $1.84B |
| Q3 2023 | 214 | $1.73B |
| Q2 2023 | 202 | $1.88B |
| Q1 2023 | 200 | $1.48B |
| Q4 2022 | 178 | $1.32B |
| Q3 2022 | 180 | $1.21B |
| Q2 2022 | 183 | $1.34B |
| Q1 2022 | 197 | $2.01B |
| Q4 2021 | 185 | $2.04B |
| Q3 2021 | 202 | $2.48B |
| Q2 2021 | 205 | $2.57B |
| Q1 2021 | 205 | $2.75B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Vericel Corp; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Fred Alger Management, LLC | 3,364,030 | $176.6M | 0.42% | +639,959+23.5% | Added |
| RTW Investments, LP | 4,517,570 | $237.2M | 3.58% | 00.0% | Unchanged |
| Brown Capital Management LLC | 4,589,819 | $241.0M | 1.83% | +19,766+0.4% | Added |
| BlackRock Inc. | 7,002,125 | $367.6M | 0.01% | −258,741−3.6% | Reduced |
| Sofos Investments, Inc. | 55 | – | – | +55 | New |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −374,435−100.0% | Sold out |
| Iron Triangle Partners LP | 0 | $0 | 0.00% | −160,000−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −122,125−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −91,400−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −70,648−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −48,797−100.0% | Sold out |
| Fort Washington Investment Advisors Inc | 0 | $0 | 0.00% | −44,327−100.0% | Sold out |
| Aviva PLC | 0 | $0 | 0.00% | −23,098−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −35,941−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −13,038−100.0% | Sold out |
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −11,483−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −11,317−100.0% | Sold out |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −10,842−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −9,121−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −9,092−100.0% | Sold out |
| Quantitative Systematic Strategies LLC | 0 | $0 | 0.00% | −6,916−100.0% | Sold out |
| Cornerstone Investment Partners, LLC | 0 | $0 | 0.00% | −6,845−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Rollins Financial | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −4,973−100.0% | Sold out |
| Athanor Capital, LP | 0 | $0 | 0.00% | −4,934−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −4,830−100.0% | Sold out |
| Hancock Whitney Corp | 0 | $0 | 0.00% | −4,147−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −3,869−100.0% | Sold out |
| Nicollet Investment Management, Inc. | 0 | $0 | 0.00% | −3,755−100.0% | Sold out |
| USA Financial Portformulas Corp | 0 | $0 | 0.00% | −3,650−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −3,631−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −3,460−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −1,670−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −607−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −544−100.0% | Sold out |
| Capital Analysts, LLC | 0 | $0 | 0.00% | −203−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Enterprise Financial Services Corp | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Waddell & Reed Financial Inc | – | – | – | – | Not filed |